secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lifeward Ltd. (LFWD)
CIK:        0001607962
Form:       8-K
Filed at:   2026-01-13T23:59:59+00:00
Accession:  0001178913-26-000132
Event type: m_and_a
Sentiment:  neutral
Materiality: 0.90
Item codes: 1.01, 2.03, 3.02, 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Lifeward acquires Oramed's POD tech; Oramed gets up to 49.99% LFWD stake; up to $47M capital
--------------------------------------------------------------------------------

- Issues Oramed shares & pre-funded warrants for 49.99% fully diluted equity (max 45% post-closing).
- Up to $47M from Oramed & another investor via $20M convertible notes (8% interest, 100% warrant coverage) and equity.
- Oramed to receive 4% of ReWalk net sales for up to 10 yrs; board expands to 6 (2 each from LFWD, Oramed, 2 external).
- Oramed funds/manages POD clinical program; $10M note funded at close, second $10M conditional on revenue or share price milestone.
- Transaction subject to shareholder approval; 120-day lock-up for officers, directors, and Oramed shares.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326000132/0001178913-26-000132-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1607962/000117891326000132/zk2634192.htm
  HTML page:      https://secwatch.observer/filing/0001178913-26-000132

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer